Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|September 25, 2009
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patientsM Bickel, A Bodtländer, G K Knecht, et al.
Haematologica|June 15, 2007
First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemiaT Wolf, V Rickerts, S Staszewski, et al.
Journal of Medicinal Chemistry|February 7, 1992
2-[(2-pyridylmethyl)sulfinyl]-1H-thieno[3,4-d]imidazoles. A novel class of gastric H+/K(+)-ATPase inhibitorsK Weidmann, A W Herling, H J Lang, et al.
The Journal of Biological Chemistry|September 15, 1992
Liver-specific drug targeting by coupling to bile acidsW Kramer, G Wess, G Schubert, et al.
Pharmacology|January 1, 1988
A substituted thieno[3.4-d]imidazole versus substituted benzimidazoles as H+, K+-ATPase inhibitorsA W Herling, M Bickel, H J Lang, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitorM Bickel, K H Baringhaus, M Gerl, et al.
The Journal of Infection|November 20, 2012
Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patientsT Wolf, U Goetsch, G Oremek, et al.
AIDS (London, England)|December 12, 2001
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individualsA N Phillips, V Miller, C Sabin, et al.
Atherosclerosis|February 6, 2007
Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosisM W Lorenz, C Stephan, A Harmjanz, et al.
The Journal of Infection|July 6, 2010
Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65RC Stephan, B Dauer, M Bickel, et al.
Pageof 16